Concepedia

Author

Jes B. Hansen

Leo Pharma (Denmark)

Also Known As

J Hansen, J. B. HANSEN, J. B. Hansen, J. Hansen, J.B. Hansen, Jacob G. Hansen, Jes B Hansen, Jes B. Hansen, Jes Birger Hansen, Jes Hansen

41

Publications

650

Citations

13

H-Index

26

Concepts

All Affiliations

Leo Pharma (Denmark)Novo Nordisk (Denmark)Linköping UniversityConnolly Hospital BlanchardstownOrthopädische Praxis
JB

About

Jes B. Hansen is an author at Leo Pharma (Denmark) specializing in medicine, extracellular matrix, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

241

2

Anatomy

1

1

16

3

Diabetes

1

1

30

4

Orthopaedics

1

1

16

5

Pathology

1

1

174

Jes B. Hansen

×

13

Publications

573

Citations

13

H-Index

YearCitations

Proliferation and Mitogenic Response to PDGF-BB of Fibroblasts Isolated from Chronic Venous Leg Ulcers is Ulcer-Age Dependent11Presented in part at the Gordon Research Conference on Wound Repair July 2–7 1995 and at an IBC meeting on Fibrosis in Washington, DC, April 18–19 1996.

Magnus S. Ågren, Henrik Steenfos, Sally Dabelsteen,

Journal of Investigative Dermatology

1999

174

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVETM European cohort

Anne Dornhorst, H-J Lüddeke, Séamus Sreenan,

International Journal of Clinical Practice

2007

83

Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study

Anne Dornhorst, Hans-Joachim Lüddeke, Séamus Sreenan,

International Journal of Clinical Practice

2008

71

Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis.

Paola Fernández Vojvodich, Jes B. Hansen, Lars Sävendahl,

PubMed

2007

47

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Marcus Schmitt‐Egenolf, Jonatan Freilich, N.M. Stelmaszuk-Zadykowicz,

Dermatology and Therapy

2021

37

Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: Evidence from the PREDICTIVE™ study

Leo Niskanen, Antti Virkamäki, Jes B. Hansen,

Diabetes Research and Clinical Practice

2009

30

Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE™ study

Séamus Sreenan, Antti Virkamäki, K. Zhang,

International Journal of Clinical Practice

2008

27

Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)

J.‐P. Lacour, Anthony Bewley, Edward R. Hammond,

Dermatology and Therapy

2020

23

Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified

Henrik Gréen, Olle Stål, K. Bachmeier,

Cancer Letters

2011

21

A case of replantation of an upper lateral incisor: A histologic study

J. J. Pindborg, Jes B. Hansen

Oral Surgery Oral Medicine Oral Pathology

1951

16

Page 1